Growth hormone and IGF-I therapy in the hypercatabolic patient

S. E. Wolf, R. E. Barrow, D. N. Herndon

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

The use of exogenous GH to increase its circulating concentration, may benefit critically ill patients by increasing their nitrogen retention and promoting the wound healing process. GH also changes protein production in wounds, causes higher levels of insulin and changes substrate utilization. Its effects are anabolic, diabetogenic and lipolytic, acting through both direct and indirect mechanisms. The effects on carbohydrate and fat metabolism are directly mediated through specific GH receptors, while its effect on protein is mediated through IGF-I. Its effects on IGF-I production and the induction of IGF binding proteins are currently being studied in an effort to better understand the mechanism of GH actions during stress.

Original languageEnglish (US)
Pages (from-to)447-463
Number of pages17
JournalBailliere's Clinical Endocrinology and Metabolism
Volume10
Issue number3
DOIs
StatePublished - 1996

Fingerprint

Insulin-Like Growth Factor I
Growth Hormone
Insulin-Like Growth Factor Binding Proteins
Carbohydrate Metabolism
Metabolism
Critical Illness
Wound Healing
Proteins
Nitrogen
Fats
Carbohydrates
Insulin
Wounds and Injuries
Substrates
Therapeutics

ASJC Scopus subject areas

  • Endocrinology
  • Biochemistry

Cite this

Growth hormone and IGF-I therapy in the hypercatabolic patient. / Wolf, S. E.; Barrow, R. E.; Herndon, D. N.

In: Bailliere's Clinical Endocrinology and Metabolism, Vol. 10, No. 3, 1996, p. 447-463.

Research output: Contribution to journalArticle

@article{22d05acd6beb4ecab5223f36cc03330a,
title = "Growth hormone and IGF-I therapy in the hypercatabolic patient",
abstract = "The use of exogenous GH to increase its circulating concentration, may benefit critically ill patients by increasing their nitrogen retention and promoting the wound healing process. GH also changes protein production in wounds, causes higher levels of insulin and changes substrate utilization. Its effects are anabolic, diabetogenic and lipolytic, acting through both direct and indirect mechanisms. The effects on carbohydrate and fat metabolism are directly mediated through specific GH receptors, while its effect on protein is mediated through IGF-I. Its effects on IGF-I production and the induction of IGF binding proteins are currently being studied in an effort to better understand the mechanism of GH actions during stress.",
author = "Wolf, {S. E.} and Barrow, {R. E.} and Herndon, {D. N.}",
year = "1996",
doi = "10.1016/S0950-351X(96)80575-1",
language = "English (US)",
volume = "10",
pages = "447--463",
journal = "Bailliere's Clinical Endocrinology and Metabolism",
issn = "0950-351X",
publisher = "Bailliere Tindall Ltd",
number = "3",

}

TY - JOUR

T1 - Growth hormone and IGF-I therapy in the hypercatabolic patient

AU - Wolf, S. E.

AU - Barrow, R. E.

AU - Herndon, D. N.

PY - 1996

Y1 - 1996

N2 - The use of exogenous GH to increase its circulating concentration, may benefit critically ill patients by increasing their nitrogen retention and promoting the wound healing process. GH also changes protein production in wounds, causes higher levels of insulin and changes substrate utilization. Its effects are anabolic, diabetogenic and lipolytic, acting through both direct and indirect mechanisms. The effects on carbohydrate and fat metabolism are directly mediated through specific GH receptors, while its effect on protein is mediated through IGF-I. Its effects on IGF-I production and the induction of IGF binding proteins are currently being studied in an effort to better understand the mechanism of GH actions during stress.

AB - The use of exogenous GH to increase its circulating concentration, may benefit critically ill patients by increasing their nitrogen retention and promoting the wound healing process. GH also changes protein production in wounds, causes higher levels of insulin and changes substrate utilization. Its effects are anabolic, diabetogenic and lipolytic, acting through both direct and indirect mechanisms. The effects on carbohydrate and fat metabolism are directly mediated through specific GH receptors, while its effect on protein is mediated through IGF-I. Its effects on IGF-I production and the induction of IGF binding proteins are currently being studied in an effort to better understand the mechanism of GH actions during stress.

UR - http://www.scopus.com/inward/record.url?scp=0029774283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029774283&partnerID=8YFLogxK

U2 - 10.1016/S0950-351X(96)80575-1

DO - 10.1016/S0950-351X(96)80575-1

M3 - Article

VL - 10

SP - 447

EP - 463

JO - Bailliere's Clinical Endocrinology and Metabolism

JF - Bailliere's Clinical Endocrinology and Metabolism

SN - 0950-351X

IS - 3

ER -